Welcome to the Department of Ophthalmic Research - a partnership between Cleveland Clinic's Cole Eye and Lerner Research Institutes. Our collective mission is to further our understanding of the molecular and cellular basis of vision loss and use this knowledge for the development of targeted therapeutics.
Our faculty are involved in multi-disciplinary and highly collaborative approaches, using both basic science and clinical investigation, which serves as the basis for exploring and evaluating diagnostic and treatment strategies to slow and prevent blindness. Disorders currently being investigated include retinitis pigmentosa, macular degeneration (juvenile and age-related forms), diabetic retinopathy, retinopathy of prematurity, ciliopathies, glaucoma, uveal melanoma and corneal disorders, such as keratoconus, infections and fibrosis.
One of the many strengths of the department is the close interaction between basic science researchers and clinicians who are committed to achieving our common goal of preventing vision loss. This cohesive community of investigators fosters innovation through collaboration and allows the movement of ideas from both "bench-to-bedside," as well as "bedside-to-bench."
Please do not hesitate to contact us for more information.
Bela Anand-Apte, MBBS, PhD, MBA
Chair, Department of Ophthalmology Research, Cole Eye Institute
The Llura and Gordon Gund Endowed Chair in Ophthalmology Research